Skip to content
★ Sign in to follow
OrbusNeich Medical Group Holdings Ltd. logo

OrbusNeich Medical Group Holdings Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$3.1BHealth Care

No insider purchase over the last 90 days. The latest, by Chen Wing Shing, was filed 18 Jun 2026.

OrbusNeich Medical Group Holdings Ltd.: what insiders have been doing

Every trade that managers of OrbusNeich Medical Group Holdings Ltd. disclose to HKEX is tracked on this page. The company sits in the Health Care sector. 1 insider has disclosed 2 filings since 22 October 2025.

The flow runs one way only: 1 insider bought (2 purchases totalling €222.3M) and nobody sold on the market. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €222.3M, bought by Chen Wing Shing and made public on 22 May 2026. On the buying side, the filings list 1 senior executive among the declarants.

For context, the typical company on the same exchange (median of 1,314 companies) published 4 filings over the same period, against 2 filings here. Over the whole record (from 2023), the tally stands at 2 purchases and no sales.

The last purchase on record was published on 18 June 2026, which is 143 days ago.

Source: insider filings from HKEX. Past trades are no guide to future returns.

Insider Decl.
7
Thresholds
n/a
Buy Volume
€222M
2 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Chen Wing Shing2 buys

Since the insiders bought

  • Filed 18 Jun 2026 · 143 days ago · €11k
    -4.6%
    Entry HK$3.91 · Close 22 Oct 2026 HK$3.73

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 11,775 of 26,897 companies
54.7
score / 100
Value
26
Quality
83
FCF yld0.0%
Earn yld1.3%
EV/EBITDA58.7x
ROE11%
Gross mgn68%
Net mgn23%
Debt/EBITDA0.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$3.81
Analyst consensus
2 analysts
1.00/5
HK$5.34Target HK$5.64(+48%)HK$5.95
Income statement
RevenueHK$180.5M
Gross profitHK$122.4M68% margin
EBITDAHK$53.5M30% margin
Net incomeHK$41.9M22.3% margin
Valuation
PER (trailing)9.3x
PER (forward)9.6x
P/Book1.0x
Beta-0.58
Balance sheet & cash
Market capHK$3.1B
Total debtHK$3.9M
Free Cash FlowHK$1.1M
Debt / Equity2%
Profitability & ownership
ROE10.6%
ROA6.2%
% insiders63.7%
% institutions11.7%
Last declaration on 18 June 2026
Declarations7 total
  • ▲
    DirectorExecutives
    100,000 HKD11HKEX
    25,000 shares@ HK$4.000.0% of flowShareXHKGHKEX:DA20260618E00028
    Canonical exit: 14 Sept 2026 (T+90)
  • ▲
    DirectorExecutives
    24M HKD19HKEX
    6,113,409 shares@ HK$4.00100.0% of flowShareXHKGHKEX:DA20260522E00044
    Canonical exit: 17 Aug 2026 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    507,143 sharesShareXHKGHKEX:DA20250415E00022
  • ●
    DirectorExecutives
    0HKEX
    521,523,844 sharesShareXHKGHKEX:DA20230106E00030
  • ●
    DirectorExecutives
    0HKEX
    507,143 sharesShareXHKGHKEX:DA20230106E00037
  • ●
    DirectorExecutives
    0HKEX
    521,523,844 sharesShareXHKGHKEX:DA20230106E00032
  • ●
    DirectorExecutives
    0HKEX
    400,000 sharesShareXHKGHKEX:DA20230106E00035

7 of 7 declarations

About OrbusNeich Medical Group Holdings Ltd.

OrbusNeich Medical Group Holdings Ltd. is a company specializing in the development and manufacturing of medical devices for the treatment of cardiovascular diseases. It focuses on innovation and improving clinical outcomes for patients.